Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy

Share :

ESMO 2014

26 - 30 Sep 2014
Published: 27 Sep 2014
Views: 2807
Rating:
Save
Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa

At a press conference at ESMO 2014, Dr Rapoport presents the results of his phase 3 trial which looked at the use of rolapitant for the prevention of chemotherapy-induced nausea and vomiting.

Read the news story and watch the interview for more.

Related Videos

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
27 Oct 2023
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )
17 Oct 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Carolyn Taylor - Executive Director, Global Focus on Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )
5 Sep 2023
War in Ukraine: The Global Medical Knowledge Alliance's response to improving...
Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care ( Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk )
22 Aug 2023
OncoAlert Round Up for August 4th - 10th, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for August 4th - 10th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
14 Aug 2023
NSIA and BVGH aim to improve patient outcomes and access to quality cancer care
Dr Tolulope Adewole - Program Lead, MedServe, Nigeria Sovereign Investment...
NSIA and BVGH aim to improve patient outcomes and access to quality cancer care ( Dr Tolulope Adewole - Program Lead, MedServe, Nigeria Sovereign Investment Authority (NSIA) )
26 May 2023
Management of prostate cancer in Africa: Looking to the future
Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA
Management of prostate cancer in Africa: Looking to the future ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )
25 May 2023
Time toxicity: the burden on cancer patients
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
The current status of multiple myeloma diagnosis and treatment
Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
The current status of multiple myeloma diagnosis and treatment ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )
24 May 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation